All GLP-1 Journey Guides
235 hand-edited guides organized by topic, category, and medication. New guides go live every day.
warning_amberCompounded GLP-1s · 5 guides
Compounded versions, microdosing, shortage status.
Compounded Semaglutide: What It Is, Risks, and What's Changed
Compounded semaglutide is no longer broadly legal after the FDA resolved the shortage. Here's what compounding is, where it stands in 2026, and the real risks.
Read guidearrow_forwardCompounded Tirzepatide: Why It's Disappearing and What's Next
The FDA declared the tirzepatide shortage resolved in late 2024. Here's where compounded tirzepatide stands in 2026, the documented risks, and your options.
Read guidearrow_forwardCompounded vs Brand-Name GLP-1: A Realistic Comparison
Compounded GLP-1s and brand-name products differ on quality, cost, dosing format, and legal status. Here's a side-by-side comparison as of 2026.
Read guidearrow_forwardGLP-1 Drug Shortages in 2026: What the FDA Status Means for You
The FDA declared semaglutide and tirzepatide shortages resolved in late 2024. Here's what the official status means for patients, prescribers, and compounded versions.
Read guidearrow_forwardMicrodosing GLP-1: What People Are Trying and What We Know
Microdosing GLP-1 means using doses smaller than the FDA-approved schedule. It's unproven and off-label. Here's what's actually known — and what isn't.
Read guidearrow_forward